Relationship between FRA11F and 11q13 gene amplification in oral cancer

Genes Chromosomes and Cancer

Volumn 46, Issue 2, 2007, Pages 143-154

  Reshmi, Shalini C ^a   Huang, Xin ^a   Schoppy, David W ^b   Black, Robert C ^b   Saunders, William S ^b,c   Smith, David I ^d   Gollin, Susanne M ^a,c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

AMPLICON; ARTICLE; CANCER GENETICS; CANCER RESEARCH; CELL LINE; CHROMOSOME; CHROMOSOME 11Q; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; COMMON FRAGILE SITE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA FLANKING REGION; DNA SEQUENCE; DNA STRAND BREAKAGE; FLUORESCENCE IN SITU HYBRIDIZATION; FRA11F GENE; GENE; GENE AMPLIFICATION; GENE DUPLICATION; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOUTH CANCER; MOUTH CARCINOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 11; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; MOUTH NEOPLASMS;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 33845499454     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20394     Document Type: Article

References (61)

1. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR. 1997. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79:380-389.
2. Arlt MF, Casper AM, Glover TW. 2003. Common fragile sites. Cytogenet Genome Res 100:92-100.
3. Arlt MF, Miller DE, Beer DG, Glover TW. 2002. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 33:82-92.
4. Arlt MF, Xu B, Durkin SG, Casper AM, Kastan MB, Glover TW. 2004. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol 24:6701-6709.
5. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. 1995. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55:949-956.
6. Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D. 1997. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet Cell Genet 79:125-131.
7. Biedler JL, Spengler BA. 1976. Metaphase chromosome anomaly: Association with drug resistance and cell-specific products. Science 191:185-187.
8. Brodeur GM 2003. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
9. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI. 2003. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590-601.
10. Casper AM, Nghiem P, Arlt MF, Glover TW. 2002. ATR regulates fragile site stability. Cell 111:779-789.
11. Champeme MH, Bieche I, Lizard S, Lidereau R. 1995. 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 12:128-133.
12. Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau V. 2002. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: The model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11:2887-2894.
13. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
14. Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M. 1998. A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 2:259-265.
15. De Lorenzo C, Mechler BM, Bryant PJ. 1999. What is Drosophila telling us about cancer? Cancer Metastasis Rev 18:295-311.
16. Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI. 2003. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer 38:40-52.
17. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. 1996. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 93:4804-4809.
18. Field JK 1992. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 28:67-76.
19. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW, Jensen RH. 2000. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 60:5405-5409.
20. Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL. 1998. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res 58:3409-3414.
21. Gollin SM 2001. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease. Head Neck 23:238-253.
22. Hamlin JL, Biedler JL. 1981. Replication pattern of a large homogenously staining chromosome region in antifolate-resistant Chinese hamster cell lines. J Cell Physiol 107:101-114.
23. Hecht F, Glover TW. 1984. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185-188.
24. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI. 2002. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1:89-97.
25. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. 2005. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 14:693-701.
26. Huang H, Qian C, Jenkins RB, Smith DI. 1998. Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer 21:152-159.
27. Huang X, Gollin SM, Raja S, Godfrey TE. 2002. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99:11369-11374.
28. Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K. 1997. Sequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion. Proc Natl Acad Sci USA 94:14584-14589.
29. Jeannon JP, Wilson JA. 1998. Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer. Clin Otolaryngol 23:420-424.
30. Jin Y, Hoglund M, Jin C, Martins C, Wennerberg J, Akervall J. 1998. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 22:312-320.
31. Katoh M, Katoh M. 2003. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13 encodes the eight-transmembrane protein homologous to C12orf3, C11orf25, and FLJ34272 gene produce. Int J Oncol 22:1375-1381.
32. Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI. 2000. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69:37-46.
33. Kuo MT, Sen S, Hittelman WN, Hsu TC. 1998. Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol 56:7-13.
34. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, Myers EN. 1995. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer 12:288-295.
35. Luo LZ, Werner KM, Gollin SM, Saunders WS. 2004. Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells. Mutat Res 554:375-385.
36. McClintock B 1938. The fusion of broken ends of sister half-chromatids following chromatid breakage at meiotic anaphases. Mo Agric Exp Stn Res Bull 290:1-48.
37. McClintock B 1939. The behavior in successive nuclear divisions of a chromosome broken in meiosis. Proc Natl Acad Sci USA 25:405-416.
38. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. 1995. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975-978.
39. Milbrandt JD, Heintz NH, White WC, Rothman SM, Hamlin JL. 1981. Methotrexate-resistant Chinese hamster ovary cells have amplified a 135-kilobase-pair region that includes the dihydrofolate reductase gene. Proc Natl Acad Sci USA 78:6043-6047.
40. Miller CT, Lin L, Casper AM, Lim J, Thomas DG, Orringer MB, Chang AC, Chambers AF, Giordano TJ, Glover TW, Beer DG. 2006. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25:409-418.
41. Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M. 1999. Cancer-specific chromosome alterations in the constitutive fragile region of FRA3B. Proc Natl Acad Sci USA 96:7456-7461.
42. Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y. 1998. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci USA 95:8141-8146.
43. Morelli C, Karayianni E, Magnanini C, Mungall AJ, Thorland E, Negrini M. 2002. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 21:7266-7276.
44. Pegram MD, Konecny G, Slamon DJ. 2000. The molecular and cellular biology of HERZ/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treat Res 103:57-75.
45. Pipiras E, Coquelle A, Bieth A, Debatisse M. 1998. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 17:325-333.
46. Ragin CC, Reshmi SC, Gollin SM. 2004. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 110:701-709.
47. Rice GC, Hoy C, Schimke RT. 1986. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83:5978-5982.
48. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene 23:6872-6880.
49. Sambrook J, Fritsch EF, Maniatis T. 1989. In: Nolan C, editor. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press.
50. Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I. 2000. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 97:303-308.
51. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A. 1999. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5:1966-1975.
52. Schuuring E, van Damme H, Schuuring-Scholtes E, Verhoeven E, Michalides R, Geelen E. 1998. Characterization of the EMS1 gene and its product, human cortactin. Cell Adhes Commun 6:185-209.
53. Shiraishi T, Druck T, Mimori K, Flomenberg J, Berk L, Alder H. 2001. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fral4A2/Fhit. Proc Natl Acad Sci USA 98:5722-5727.
54. Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM. 2000. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28:153-163.
55. Singer MJ, Mesner LD, Friedman CL, Trask BJ, Hamlin JL. 2000. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc Natl Acad Sci USA 97:7921-7926.
56. Stark GR 1993. Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 61:87-113.
57. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG. 2001. The sequence of the human genome. Science 291:1304-1351.
58. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K. 1996. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93:9770-9775.
59. Watson KL, Justice RW, Bryant PJ. 1994. Drosophila in cancer research: The first fifty tumor suppressor genes. J Cell Sci Suppl 18:19-33.
60. Windle B, Draper BW, Yin YX, O'Gorman S, Wahl GM. 1991. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev 5:160-174.
61. Zimonjic DB, Durkin ME, Keck-Waggoner CL, Park SW, Thorgeirsson SS, Popescu NC. 2003. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma. Neoplasia 5:390-396.